Learn more

FEDERALNOE GOSUDARSTVENNOE BYUDZHETNOE UCHREZHDENIE NAUKI KIROVSKIJ NAUCHNO ISSLEDOVATELSKIJ INST GE

Overview
  • Total Patents
    24
  • GoodIP Patent Rank
    67,031
  • Filing trend
    ⇩ 28.0%
About

FEDERALNOE GOSUDARSTVENNOE BYUDZHETNOE UCHREZHDENIE NAUKI KIROVSKIJ NAUCHNO ISSLEDOVATELSKIJ INST GE has a total of 24 patent applications. It decreased the IP activity by 28.0%. Its first patent ever was published in 2016. It filed its patents most often in Russian Federation. Its main competitors in its focus markets measurement, biotechnology and basic materials chemistry are SHANGHAI INNOSTAR BIO TECH CO LTD, ANALYSIS AND DETERMINATION CENTER SICHUAN ACAD OF AGRICULTURAL SCIENCES and MICROSENS MEDTECH LTD.

Patent filings in countries

World map showing FEDERALNOE GOSUDARSTVENNOE BYUDZHETNOE UCHREZHDENIE NAUKI KIROVSKIJ NAUCHNO ISSLEDOVATELSKIJ INST GEs patent filings in countries
# Country Total Patents
#1 Russian Federation 24

Patent filings per year

Chart showing FEDERALNOE GOSUDARSTVENNOE BYUDZHETNOE UCHREZHDENIE NAUKI KIROVSKIJ NAUCHNO ISSLEDOVATELSKIJ INST GEs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Kostyaev Andrej Aleksandrovich 11
#2 Vetoshkin Konstantin Aleksandrovich 7
#3 Utemov Sergej Vyacheslavovich 7
#4 Zajtseva Galina Alekseevna 5
#5 Perfilova Elena Aleksandrovna 5
#6 Minaeva Natalya Viktorovna 5
#7 Butina Elena Vladimirovna 5
#8 Sherstnev Filipp Sergeevich 5
#9 Fedorovskaya Nadezhda Stanislavovna 4
#10 Isaeva Natalya Vasilevna 3

Latest patents

Publication Filing date Title
RU2738863C1 Method for morphometric estimation of prediction of clinical course of nodular sclerosis of hodgkin lymphoma by a percentage score cd163+ and cd68+ macrophages in lymph nodes
RU2735782C1 Method for producing a standard sample of human igg antibody content to tick-borne encephalitis virus
RU2744614C1 Method for reducing toxicity of cryopreservation solution based on dimethyl sulfoxide after thawing of hematopoietic stem cells
RU2726439C1 Method for prediction of chronic myeloid leukaemia development risk
RU2723164C1 Method for calculating the dose of haematopoiesis precursor cells in a leukocytapheresis product by taking into account the change in the integrity of cell membranes during storage
RU2722173C1 Method for predicting growth rate of culture by amount of aldehyde dehydrogenase-positive bone marrow mesenchymal cells of donors
RU2710591C1 Method for morphometric assessment of the prediction of diffuse b-large-cell lymphoma by content of stat3+ cells in tumor tissue
RU2698453C1 Method for prediction of clinical course of haemophilia with level of activity factors viii, ix
RU2708631C1 Method of completing cryopreserved erythrocyte reserve based on immunohematological criteria
RU2716574C1 Method for adrift freezing of peripheral blood precursor cells at a temperature of minus 80 °c with a solution of hemodiolite
RU2711152C1 Method for unstructured freezing peripheral blood precursor cells at minus 80 °c with a hemicolite solution
RU2720771C1 Method for unregulated freezing of peripheral blood precursor cells at temperature of minus 80 °c with gemgel solution
RU2694838C1 Method for morphometric assessment of a diffuse b-large-cell lymphoma prediction by stat3+ tumor cell count in lymph nodes
RU2707921C1 Method for unrestricted freezing peripheral blood precursor cells at minus 80 °c under protection of dimethylsulphoxid
RU2676674C1 Method for identifying an effective cryoprotector by cytochemical index of the content of leukocyte alkaline phosphatase of autologous blood
RU2686107C1 Method of optimal cryoprotector selection having glycogen content in preserved blood leukocytes
RU2689334C1 Method for determining a personalized cryoprotector by leukocyte acid phosphatase of preserved blood
RU2689328C1 Method for determining an optimal cryoprotector according to a cytochemical indicator of content of succinate dehydrogenase in blood plasma leukocytes
RU2665827C1 Method of diagnostics of genetic disorders in pathology of human reproduction process
RU2639892C1 Method for human nucleated blood cells cryopreservation at temperature of minus 80°c